Lensar (LNSR) Cash from Investing Activities (2019 - 2026)
Lensar's (LNSR) quarterly Cash from Investing Activities came in at $4.0 million in Q1 2026, up 653.3% year-on-year from $531000.0 in Q1 2025, and down 5.77% on a QoQ basis from $4.2 million in Q4 2025.
Lensar (LNSR) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Cash from Investing Activities data on file, last reported at $4.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 653.3% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 1276.49% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 159.42% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $4.0 million, down from $4.2 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for LNSR reached as high as $4.2 million in Q4 2025 and fell as low as -$7.5 million in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$67529.4 across 5 years, with a median of -$10000.0 in 2022.
- Across the five-year window, Cash from Investing Activities sank 45150.0% in 2024 and surged 653.3% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at -$57000.0 in 2022, then tumbled by 6856.14% to -$4.0 million in 2023, then surged by 150.24% to $2.0 million in 2024, then jumped by 113.1% to $4.2 million in 2025, then fell by 5.77% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $4.0 million in Q1 2026, $4.2 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 4.25 Mn |
| Dec 31, 2025 | 4.25 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Mar 31, 2025 | 531,000.00 |
| Mar 31, 2025 | 531,000.00 |
| Dec 31, 2024 | 1.99 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | -905,000.00 |
| Sep 30, 2024 | -905,000.00 |
| Jun 30, 2024 | -2.02 Mn |
| Jun 30, 2024 | -2.02 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Dec 31, 2023 | -3.97 Mn |
| Dec 31, 2023 | -3.97 Mn |